BMS-262084
| CAS No. | 253174-92-4 | Cat. No. | BCP45717 |
| Name | BMS-262084 | ||
| Synonyms | BMS 262084; BMS262084; BDBM50120368; DNC004491; | ||
| Formula | C18H31N7O5 | M. Wt | 425.48 |
| Description | BMS-262084 is a potent and selective beta-lactam tryptase inhibitor with therapeutic potential for treating asthma. Coadministration of aprotinin, a trypsin inhibitor, increased the oral absorption of BMS-262084 several fold. In vitro, using Caco-2 cells, BMS-262084 appeared to be a P-gp substrate, with an efflux ratio of 14. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Factor Xa | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.